Our previous research showed that in ccRCC, ZHX2 can be regulated by pVHL potentially through hydroxylation on multiple proline residues in the PRR domain (Zhang et al., 2018). This evidence concerns the gene ZHX2 and nonpapillary renal cell carcinoma.